Research needs in allergy: an EAACI position paper, in collaboration with EFA
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
In less than half a century, allergy, originally perceived as a rare disease, has become a major public health threat, today affecting the lives of more than 60 million people in Europe, and probably close to one billion worldwide, thereby heavily impacting the budgets of public health systems. More disturbingly, its prevalence and impact are on the rise, a development that has been associated with environmental and lifestyle changes accompanying the continuous process of urbanization and globalization. Therefore, there is an urgent need to prioritize and concert research efforts in the field of allergy, in order to achieve sustainable results on prevention, diagnosis and treatment of this most prevalent chronic disease of the 21 st century. The European Academy of Allergy and Clinical Immunology (EAACI) is the leading professional organization in the field of allergy, promoting excellence in clinical care, education, training and basic and translational research, all with the ultimate goal of improving the health of allergic patients. The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is a non‐profit network of allergy, asthma and Chronic Obstructive Pulmonary Disorder (COPD) patients’ organizations. In support of their missions, the present EAACI Position Paper, in collaboration with EFA, highlights the most important research needs in the field of allergy to serve as key recommendations for future research funding at the national and European levels. Although allergies may involve almost every organ of the body and an array of diverse external factors act as triggers, there are several common themes that need to be prioritized in research efforts. As in many other chronic diseases, effective prevention, curative treatment and accurate, rapid diagnosis represent major unmet needs. Detailed phenotyping/endotyping stands out as widely required in order to arrange or re‐categorize clinical syndromes into more coherent, uniform and treatment‐responsive groups. Research efforts to unveil the basic pathophysiologic pathways and mechanisms, thus leading to the comprehension and resolution of the pathophysiologic complexity of allergies will allow for the design of novel patient‐oriented diagnostic and treatment protocols. Several allergic diseases require well‐controlled epidemiological description and surveillance, using disease registries, pharmacoeconomic evaluation, as well as large biobanks. Additionally, there is a need for extensive studies to bring promising new biotechnological innovations, such as biological agents, vaccines of modified allergen molecules and engineered components for allergy diagnosis, closer to clinical practice. Finally, particular attention should be paid to the difficult‐to‐manage, precarious and costly severe disease forms and/or exacerbations. Nonetheless, currently arising treatments, mainly in the fields of immunotherapy and biologicals, hold great promise for targeted and causal management of allergic conditions. Active involvement of all stakeholders, including Patient Organizations and policy makers are necessary to achieve the aims emphasized herein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808
A longitudinal, population-based, cohort study of childhood asthma followed to adulthood
Sears, M. R., Greene, J. M., Willan, A. R., Wiecek, E. M., Taylor, D. R., Flannery, E. M., Cowan, J. O., Herbison, G. P., Silva, P. A., & Poulton, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022363 · Cited by 1,460 · cited 1×
“An additional significant unresolved problem in the management of asthma is the failure to prevent and/or promptly treat asthma exacerbations, which are associated with significant morbidity, risk of death and high treatment cost [54] and whose prevention in children may reduce the risk of subsequent adulthood asthma…”
BackgroundMjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166 · cited 1×
“The demonstration of IL-13 and IL-5 production by so-called type-2 ILCs in allergic inflamed tissue is a strong hint that these cells can have an important role in the Th2-type skewing in allergic tissues, even in the absence of direct involvement of antigens [26].”
BackgroundRole of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006 · cited 1×
“This needs to include studies to determine mechanisms underlying deficient antiviral immune responses reported in asthma [87] and define the roles of interactions between different viruses, including the recently identified rhinovirus-C [88], viral-bacterial synergistic effects, which accentuate airway inflammation [8…”
BackgroundSelf-citation(1996) · European Respiratory Journal · doi:10.1183/09031936.96.09040687 · Cited by 1,002
Bisgaard, H., Li, N., Bonnelykke, K., Chawes, B. L. K., Skov, T., Paludan-Müller, G., Stokholm, J., Smith, B., & Krogfelt, K. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.060 · Cited by 786 · cited 1×
“There is also emerging evidence that exposure to both commensal and pathogenic bacteria may influence the development of allergy [82].”
BackgroundPatient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective
Patrick, D. L., Burke, L. B., Powers, J. H., Scott, J. A., Rock, E. P., Dawisha, S., O'Neill, R., & Kennedy, D. L. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00275.x · Cited by 726 · cited 1×
“Patient-reported outcomes (PROs) refers to all healthrelated reports coming from the patient, without involvement or interpretation by physician or others [43] (i.”
BackgroundEpidemiologic risks for food allergy
Lack, G. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.032 · Cited by 700 · cited 1×
“A relatively recent hypothesis in the prevention field is that high dose oral exposure to food allergens in early infancy may promote the development of immunological tolerance [125].”
BackgroundSun, K., & Metzger, D. W. (2008) · Nature Medicine · doi:10.1038/nm1765 · Cited by 587
Soyka, M. B., Wawrzyniak, P., Eiwegger, T., Holzmann, D., Treis, A., Wanke, K., Kast, J. I., & Akdis, C. A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.05.052 · Cited by 486
Diagnostic tools in Rhinology EAACI position paper
Scadding, G., Hellings, P., Alobid, I., Bachert, C., Fokkens, W., van Wijk, R. G., Gevaert, P., Guilemany, J., Kalogjera, L., Lund, V., et al. (2011) · Clinical and Translational Allergy · doi:10.1186/2045-7022-1-2 · Cited by 220 · cited 1×
“Diagnosis-wise, there is a need for objective evaluation tools of disease severity and impact [63].”
BackgroundSelf-citationThe Intraepithelial T Cell Response to NKG2D-Ligands Links Lymphoid Stress Surveillance to Atopy
Strid, J., Sobolev, O., Zafirova, B., Polic, B., & Hayday, A. (2011) · Science · doi:10.1126/science.1211250 · Cited by 155
Moscato, G., Pala, G., Boillat, M. A., Folletti, I., Gerth van Wijk, R., Olgiati-Des Gouttes, D., Perfetti, L., Quirce, S., Siracusa, A., Walusiak-Skorupa, J., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02615.x · Cited by 67
Self-citation
Cited by
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology
Muraro, A., Roberts, G., Worm, M., Bilò, M. B., Brockow, K., Fernández Rivas, M., Santos, A. F., Zolkipli, Z. Q., Bellou, A., Beyer, K., et al. (2014) · Allergy · doi:10.1111/all.12437 · Cited by 1,057
Self-citationSublingual immunotherapy: World Allergy Organization position paper 2013 update
Canonica, G. W., Cox, L., Pawankar, R., Baena-Cagnani, C. E., Blaiss, M., Bonini, S., Bousquet, J., Calderón, M., Compalati, E., Durham, S. R., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-6 · Cited by 591
Self-citationD’Amato, G., Holgate, S. T., Pawankar, R., Ledford, D. K., Cecchi, L., Al-Ahmad, M., Al-Enezi, F., Al-Muhsen, S., Ansotegui, I., Baena-Cagnani, C. E., et al. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0073-0 · Cited by 581
Self-citationThe epidemiology of food allergy in Europe: a systematic review and meta‐analysis
Nwaru, B. I., Hickstein, L., Panesar, S. S., Muraro, A., Werfel, T., Cardona, V., Dubois, A. E. J., Halken, S., Hoffmann‐Sommergruber, K., Poulsen, L. K., et al. (2014) · Allergy · doi:10.1111/all.12305 · Cited by 513
Self-citationFirst European data from the network of severe allergic reactions (NORA)
Worm, M., Moneret‐Vautrin, A., Scherer, K., Lang, R., Fernandez‐Rivas, M., Cardona, V., Kowalski, M. L., Jutel, M., Poziomkowska‐Gesicka, I., Papadopoulos, N. G., et al. (2014) · Allergy · doi:10.1111/all.12475 · Cited by 327
Self-citation
Metadata
- Authors
- Papadopoulos, N. G., Agache, I., Bavbek, S., Bilo, B. M., Braido, F., Cardona, V., Custovic, A., de Monchy, J., Demoly, P., Eigenmann, P., Gayraud, J., Grattan, C., Heffler, E., Hellings, P. W., Jutel, M., Knol, E., Lötvall, J., Muraro, A., Poulsen, L. K., Roberts, G., Schmid‐Grendelmeier, P., Skevaki, C., Triggiani, M., van Ree, R., Werfel, T., Flood, B., Palkonen, S., Savli, R., Allegri, P., Annesi‐Maesano, I., Annunziato, F., Antolin‐Amerigo, D., Apfelbacher, C., Blanca, M., Bogacka, E., Bonadonna, P., Bonini, M., Boyman, O., Brockow, K., Burney, P., Buters, J., Butiene, I., Calderon, M., Cardell, L. O., Caubet, J., Celenk, S., Cichocka‐Jarosz, E., Cingi, C., Couto, M., de Jong, N., Del Giacco, S., Douladiris, N., Fassio, F., Fauquert, J., Fernandez, J., Rivas, M. F., Ferrer, M., Flohr, C., Gardner, J., Genuneit, J., Gevaert, P., Groblewska, A., Hamelmann, E., Hoffmann, H. J., Hoffmann‐Sommergruber, K., Hovhannisyan, L., Hox, V., Jahnsen, F. L., Kalayci, Ö., Kalpaklioglu, A. F., Kleine‐Tebbe, J., Konstantinou, G., Kurowski, M., Lau, S., Lauener, R., Lauerma, A., Logan, K., Magnan, A., Makowska, J., Makrinioti, H., Mangina, P., Manole, F., Mari, A., Mazon, A., Mills, C., Mingomataj, E., Niggemann, B., Nilsson, G., Ollert, M., O'Mahony, L., O'Neil, S., Pala, G., Papi, A., Passalacqua, G., Perkin, M., Pfaar, O., Pitsios, C., Quirce, S., Raap, U., Raulf‐Heimsoth, M., Rhyner, C., Robson‐Ansley, P., Alves, R. R., Roje, Z., Rondon, C., Rudzeviciene, O., Ruëff, F., Rukhadze, M., Rumi, G., Sackesen, C., Santos, A. F., Santucci, A., Scharf, C., Schmidt‐Weber, C., Schnyder, B., Schwarze, J., Senna, G., Sergejeva, S., Seys, S., Siracusa, A., Skypala, I., Sokolowska, M., Spertini, F., Spiewak, R., Sprikkelman, A., Sturm, G., Swoboda, I., Terreehorst, I., Toskala, E., Traidl‐Hoffmann, C., Venter, C., Vlieg‐Boerstra, B., Whitacker, P., Worm, M., Xepapadaki, P., & Akdis, C. A.
- Venue
- Clinical and Translational Allergy
- Publisher
- Wiley
- Published
- 2012-01
- Volume
- 2
- Issue
- 1
- Pages
- 21-21
- ISSN
- 2045-7022 (ISSN-L)
- OpenAlex
- W2172112917
- Cited by
- 204
- References
- 16
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.